<DOC>
	<DOCNO>NCT01344629</DOCNO>
	<brief_summary>To investigate bioequivalence telmisartan administrate two different way : telmisartan 80 mg/amlodipine 5 mg fixed-dose combination tablet ( T ) telmisartan 80 mg tablet amlodipine 5 mg tablet ( R ) concomitant use</brief_summary>
	<brief_title>Bioequivalence Study Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet Telmisartan 80 mg Tab Amlodipine 5 mg Tab Concomitant Use</brief_title>
	<detailed_description>Purpose :</detailed_description>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : 1 . Without clinically significant finding complication basis complete medical history , include physical examination , vital sign ( blood pressure , pulse rate , body temperature ) , 12lead electrocardiogram ( ECGs ) , clinical laboratory test 2 . Age : =20 =35 year 3 . Body weight : =50 kg =80 kg 4 . Body mass index ( BMI ) : =18.0 =25.0 kg/m2 Exclusion criterion : 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological , hormonal disorder 2 . Diseases central nervous system ( epilepsy ) psychiatric neurological disorder 3 . Chronic relevant acute infection 4 . Any clinical relevant finding laboratory test result deviate normal 5 . A positive result hepatitis B surface antigen ( HBsAg ) , antihepatitis C virus ( HCV ) antibody , syphilis test , human immunodeficiency virus ( HIV ) test 6 . History surgery gastrointestinal tract ( except appendectomy ) 7 . History relevant orthostatic hypotension , faint spell , blackouts 8 . Known hypersensitivity component formulation ( telmisartan amlodipine ) , angiotensin receptor blocker , dihydropyridine calcium channel blocker compound 9 . Intake drug long halflife ( =24 hour ) within least 1 month less 10 halflives respective drug drug administration 10 . Intake drug might reasonably influence result trial basis knowledge time protocol preparation within 7 day drug administration 11 . Participation another trial investigational drug within 1 month less 10 time halflives investigational product drug administration 12 . Smoker ( =20 cigarettes/day ) 13 . Alcohol abuse ( 60 g ethanol/day : e.g. , 3 middlesized bottle beer , 3 gous [ equivalent 540 mL ] sake ) 14 . Drug abuse 15 . Blood donation ( 100 mL within 4 week drug administration ) 16 . Excessive physical activity ( ex . Marathon etc ) within 1 week drug administration 17 . Intake alcohol within 2 day drug administration 18 . Inability comply dietary regimen study site 19 . Inability refrain smoke trial day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>